Trisomy 13, unspecified
ICD-10 Q91.7 is a billable code used to indicate a diagnosis of trisomy 13, unspecified.
Trisomy 13, also known as Patau syndrome, is a chromosomal disorder caused by the presence of an extra 13th chromosome. This condition is characterized by severe intellectual disability and multiple congenital anomalies. Common physical features include cleft lip and/or palate, polydactyly, and heart defects. Infants with Trisomy 13 often present with microcephaly, holoprosencephaly (failure of the brain to properly divide into two hemispheres), and other neurological deficits. The prognosis for children with Trisomy 13 is generally poor, with many affected individuals not surviving past the first year of life. Diagnosis is typically made through karyotyping, which reveals the presence of an extra chromosome 13. Management of Trisomy 13 is supportive, focusing on the treatment of associated congenital anomalies and providing palliative care as needed.
Detailed clinical notes on physical examination findings, developmental milestones, and management plans.
Management of infants with Trisomy 13 in the NICU, including feeding difficulties and respiratory support.
Pediatric coders must ensure that all congenital anomalies are documented and coded accurately to reflect the complexity of care.
Comprehensive genetic counseling notes, including family history and results of chromosomal analysis.
Genetic counseling sessions for families with a diagnosis of Trisomy 13, discussing implications and management options.
Genetic coders should focus on the accuracy of genetic testing documentation and the implications for family planning.
Used to confirm diagnosis of Trisomy 13 through genetic testing.
Documentation of the reason for testing and results.
Genetic specialists must ensure accurate coding of tests performed.
The prognosis for children with Trisomy 13 is generally poor, with many not surviving past the first year of life due to severe congenital anomalies and associated health complications.
